Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow up

[1]  E. Rakovitch,et al.  Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. , 2013, Current oncology.

[2]  P. Tartter,et al.  The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ. , 2013, American journal of surgery.

[3]  Armanda D. Tatsas,et al.  Borderline Atypical Ductal Hyperplasia/Low-grade Ductal Carcinoma In Situ on Breast Needle Core Biopsy Should Be Managed Conservatively , 2013, The American journal of surgical pathology.

[4]  A. Gavin,et al.  Increased diagnosis and detection rates of carcinoma in situ of the breast , 2012, Breast Cancer Research and Treatment.

[5]  M. Pike,et al.  Re: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.

[6]  T. Julian,et al.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.

[7]  R. Peto,et al.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. , 2010, Journal of the National Cancer Institute. Monographs.

[8]  William D. Dupont,et al.  Statistical Modeling for Biomedical Researchers: A Simple Introduction to the Analysis of Complex Data , 2009 .

[9]  M. Silverstein,et al.  Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ. , 2008, American journal of surgery.

[10]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  W. Dupont,et al.  The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up , 2005, Cancer.

[12]  D. Page,et al.  Special Types of Invasive Breast Cancer, With Clinical Implications , 2003, The American journal of surgical pathology.

[13]  J. Sloane,et al.  Histopathologic Types of Benign Breast Lesions and the Risk of Breast Cancer: Case–Control Study , 2002, The American journal of surgical pathology.

[14]  L Duchateau,et al.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  B. Cutuli.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of protocol B‐17 , 2000, Cancer.

[16]  S. Martino,et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.

[17]  G. Colditz,et al.  Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  K. Kerlikowske,et al.  Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.

[19]  W. Dupont,et al.  Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy , 1995, Cancer.

[20]  Peter J Lewis,et al.  Risk factors for breast cancer , 1995, BMJ.

[21]  A. Patchefsky,et al.  Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.

[22]  D. Page,et al.  Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. , 1992, Human pathology.

[23]  F. Tavassoli,et al.  A comparison of the results of long‐term follow‐up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast , 1990, Cancer.

[24]  M. Lagios,et al.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence , 1989, Cancer.

[25]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[26]  W. Dupont,et al.  Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .

[27]  David L. Page,et al.  Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.

[28]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[29]  W. Dupont,et al.  Intraductal carcinoma of the breast: Follow‐up after biopsy only , 1982, Cancer.

[30]  P. Rosen,et al.  The clinical significance of pre‐invasive breast carcinoma , 1980, Cancer.

[31]  武幹 進,et al.  喉頭の Epithelial Hyperplasia , 1980 .

[32]  P. Rosen,et al.  Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. , 1978 .

[33]  C. Lawton,et al.  Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group , 2010 .

[34]  Donald L Weaver,et al.  Protocol for the Examination of Specimens from Patients with Ductal Carcinoma In Situ ( DCIS ) of the Breast Protocol applies to DCIS without invasive carcinoma or microinvasion , 2010 .

[35]  M. Morrow.  Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group , 2007 .

[36]  D. Cosgrove.  The breast , 1999, European Radiology.

[37]  U. Chetty,et al.  Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. , 1993, Human pathology.

[38]  P. Rosen,et al.  Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. , 1978, JAMA.